BioMarin Pharmaceutical Inc. Financial Ratios — BMRN Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-4.19	-7.96	-9.25	-5.68	-5.54	-16.26	-2.7	-1.7	-0.52	16.21	-1.08	2.29	2.54	6.17	4.79
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	66.75	47.01	98.99	61.07
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.98	2.81	6.06	4.57
Gross Margin (%)	80.96	81.66	83.88	83.68	82.92	81.23	81.59	78.86	78.91	71.82	74.52	76	78.01	79.67	77.73
EBITDA Margin (%)	0.26	-13.16	-21.71	-15.28	-26.33	-9.62	-3.95	-3.98	0.03	0.72	1.83	7.6	11.99	20	15.18
Operating Margin (%)	-7.68	-22.01	-28.27	-21.41	-31.63	-18.29	-10.63	-10.4	-6.15	-4.94	-4.03	2.74	7.68	16.62	12.71
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	52.75	39.72	66.36	-17.63
Pretax Margin (%)	-9.88	-23.62	-32.18	-16.66	-17.39	-74.41	-2.73	-9.57	-5.56	-2.63	-4.08	7.14	7.79	18.98	14.98
Profit Margin (%)	-12.2	-22.84	-32.15	-17.88	-19.31	-56.43	-8.91	-5.18	-1.4	45.9	-3.47	6.75	6.93	14.96	10.83
Net Income to Common Margin (%)	-12.2	-22.84	-32.15	-17.88	-19.31	-56.43	-8.91	-5.18	-1.4	45.9	-3.47	6.75	6.93	14.96	10.83
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.36	11.09	21.21	27.69
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	348	348	656	643	662	683	1,174	830	859	1,087	1,090	1,093	1,096	603	606
ST Debt	- -	23	- -	- -	- -	22	361	- -	373	12	10	10	503	8	9
LT Debt	348	325	656	643	662	661	814	830	486	1,075	1,079	1,083	593	595	597
Total Debt/EBITDA	301.32	-5.29	-5.51	-5.61	-2.83	-6.36	-22.66	-13.99	1,808.04	81.48	32.32	6.86	3.78	1.06	1.24
Net Debt/EBITDA	261.29	-2.55	-0.73	2.03	-1.13	-2.56	-11.12	-5.67	864.58	31.94	14.59	2.25	1.14	-0.61	-1.46
Total Debt/EBIT	-10.28	-3.16	-4.23	-4.01	-2.35	-3.34	-8.41	-5.36	-8.19	-11.84	-14.66	19.05	5.9	1.27	1.48
Net Debt/EBIT	-8.91	-1.52	-0.56	1.45	-0.94	-1.35	-4.13	-2.17	-3.92	-4.64	-6.62	6.24	1.79	-0.73	-1.74
EBITDA to Interest Expense	0.14	-9.86	-12.7	-3.44	-6.7	-2.97	-1.33	-1.36	0.02	0.49	2.29	11.54	16.74	45.05	44.87
EBITDA-CapEx/Interest Expense	-18.2	-16.54	-19.66	-6.95	-13.22	-7.08	-6.44	-4.67	-7.6	-4.52	-5.8	2.02	10.53	37.36	34.69
EBIT to Interest Expense	-4.03	-16.5	-16.55	-4.82	-8.05	-5.65	-3.58	-3.55	-4.89	-3.34	-5.04	4.16	10.72	37.44	37.57
Interest Expense	8	7	9	33	35	36	39	44	21	27	15	14	17	13	11
Common Equity/Total Assets	-32.55	-34.39	-31.89	-34.32	-27.39	-37.78	-35.34	-38.26	-36.68	-14.73	-15.5	-12.38	-9.08	-2.78	2.03
Long-Term Debt/Equity (%)	45.06	31.98	48.88	42.08	27.59	23.89	28.96	27.98	15.57	26.18	25.3	23.53	11.98	10.52	9.81
Long-Term Debt/Capital (%)	-454.4	-170	-1,090.96	-311	-184.42	-78.94	-175.74	-96.16	-56.43	476.84	678.81	355.81	125.02	145.79	78.55
Long-Term Debt/Total Assets (%)	26.68	20.71	29.21	25.97	17.76	16.42	17.56	18.76	10.37	18.38	17.97	16.99	8.67	8.52	7.86
Total Debt/Equity (%)	45.06	34.28	48.88	42.08	27.59	24.7	41.82	27.98	27.51	26.47	25.54	23.75	22.13	10.65	9.95
Total Debt/Capital (%)	-454.4	-182.22	-1,090.96	-311	-184.42	-81.62	-253.72	-96.16	-99.66	482.05	685.4	359.22	230.98	147.65	79.69
Total Debt/Total Assets (%)	26.68	22.2	29.21	25.97	17.76	16.98	25.35	18.76	18.31	18.59	18.14	17.15	16.02	8.62	7.98
Net Debt to Equity	39.07	16.51	6.47	-15.22	11.05	9.94	20.52	11.34	13.15	10.37	11.53	7.79	6.7	-6.15	-11.74
Net Debt/Capital (%)	-245.72	-45.13	-13.8	21.49	-35.08	-22.07	-54.33	-24.78	-31.61	-100.54	-114.82	-85.32	-118.2	65.04	129.58
EBITDA	1	-66	-119	-115	-234	-107	-52	-59	- -	13	34	159	290	571	489
EBITDA-CapEx	-153	-110	-184	-232	-462	-256	-251	-204	-163	-124	-86	28	183	473	378
Operating Income (Loss)	-34	-110	-155	-160	-282	-204	-140	-155	-105	-92	-74	57	186	474	409

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.07	2.63	4.28	4.01	1.33	1.8	1.71	2.07	0.81	2.16	1.86	2.19	0.91	1.87	2.06
Current Ratio	4.99	4.36	6.21	5.93	2.45	3.24	2.7	3.93	2.08	4.76	4.16	4.67	2.51	5.33	5.21
Quick Ratio	3.19	3.27	4.99	4.86	1.7	2.29	2.03	2.73	1.21	3.07	2.54	2.98	1.45	2.96	3.25
CFO/Avg Current Liab	0.21	0.13	-0.32	-0.34	-0.64	-0.52	-0.01	0.03	0.07	0.12	0.59	0.31	0.18	0.64	1.21
Common Equity/Total Assets	-32.55	-34.39	-31.89	-34.32	-27.39	-37.78	-35.34	-38.26	-36.68	-14.73	-15.5	-12.38	-9.08	-2.78	2.03
Long-Term Debt/Equity (%)	45.06	31.98	48.88	42.08	27.59	23.89	28.96	27.98	15.57	26.18	25.3	23.53	11.98	10.52	9.81
Long-Term Debt/Capital (%)	-454.4	-170	-1,090.96	-311	-184.42	-78.94	-175.74	-96.16	-56.43	476.84	678.81	355.81	125.02	145.79	78.55
Long-Term Debt/Total Assets (%)	26.68	20.71	29.21	25.97	17.76	16.42	17.56	18.76	10.37	18.38	17.97	16.99	8.67	8.52	7.86
Total Debt/Equity (%)	45.06	34.28	48.88	42.08	27.59	24.7	41.82	27.98	27.51	26.47	25.54	23.75	22.13	10.65	9.95
Total Debt/Capital (%)	-454.4	-182.22	-1,090.96	-311	-184.42	-81.62	-253.72	-96.16	-99.66	482.05	685.4	359.22	230.98	147.65	79.69
Total Debt/Total Assets (%)	26.68	22.2	29.21	25.97	17.76	16.98	25.35	18.76	18.31	18.59	18.14	17.15	16.02	8.62	7.98
CFO/Total Liabilities	3.46	3.19	-6.35	-7.43	-16.52	-18.12	-0.48	1.38	3.08	4.9	17.51	9.93	8.43	43.04	54.94
CFO/CapEx	0.12	0.4	-0.88	-0.6	-0.96	-1.54	-0.04	0.14	0.3	0.62	2.55	1.34	1.48	5.88	7.46
Altman's Z-Score	4.51	6.48	6.53	8.57	7.33	6.41	5.17	6.32	5.83	5.95	6.01	7.14	6.43	6.75	5.74

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	4.61	4.68	4.83	5.71	5.75	5.87	5.51	4.94	4.73	4.51	4.49	5.02	4.42	4.41	4.11
Days Sales Outstanding	79.15	77.96	75.49	63.89	63.46	62.13	66.22	73.92	77.11	81	81.23	72.68	82.61	82.76	88.88
Inventory Turnover	0.7	0.71	0.61	0.68	0.65	0.67	0.58	0.63	0.59	0.76	0.64	0.6	0.53	0.5	0.57
Days Inventory Outstanding	520.89	514.36	601.44	540.42	565.64	545.71	627.16	582.73	614.9	479.97	572.2	606.16	686.44	735.94	643.96
Accounts Payable Turnover	5.09	1.75	1.51	1.36	1.41	1.58	2.02	1.98	2.27	2.51	2.81	2.88	2.73	2.56	2.86
Accounts Payable Turnover Days	71.72	208.4	242.41	269.33	259.47	230.81	180.25	184.41	160.89	145.45	130.1	126.75	133.91	142.47	127.66
Cash Conversion Cycle	528.32	383.92	434.53	334.98	369.63	377.03	513.13	472.23	531.13	415.52	523.33	552.08	635.14	676.24	605.18
Inventory to Cash Days	-441.74	-436.39	-525.95	-476.53	-502.18	-483.58	-560.95	-508.81	-537.78	-398.97	-490.97	-533.48	-603.84	-653.18	-555.08
Inventories	130	129	163	199	272	355	476	531	680	699	777	894	1,107	1,233	1,299
Raw Materials	12	12	15	22	46	51	50	75	74	77	80	131	156	154	107
Work In Process	76	71	88	114	150	168	235	231	350	308	415	411	571	551	801
Finished Goods	42	45	59	63	75	136	191	225	256	314	281	352	380	528	391
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	3,855	5,917	9,691	13,230	16,764	13,750	15,554	15,077	15,138	15,855	16,155	19,173	18,111	12,490	11,398
- Cash & Cash Equivalents	46	181	569	875	397	408	598	494	437	649	587	725	755	943	1,312
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	348	348	656	643	662	683	1,174	830	859	1,087	1,090	1,093	1,096	603	606
Enterprise Value	4,008	5,818	9,562	12,928	16,834	13,644	15,332	14,823	15,243	15,876	16,231	18,975	18,133	11,955	10,443
Total Capital	-77	-191	-60	-207	-359	-837	-463	-864	-862	225	159	304	474	408	760
Total Debt/Capital (%)	-454.4	-182.22	-1,090.96	-311	-184.42	-81.62	-253.72	-96.16	-99.66	482.05	685.4	359.22	230.98	147.65	79.69
Total Debt / EV	0.09	0.06	0.07	0.05	0.04	0.05	0.08	0.06	0.06	0.07	0.07	0.06	0.06	0.05	0.06
EV/Sales	9.08	11.62	17.43	17.25	18.92	12.22	11.67	9.94	8.95	8.53	8.79	9.05	7.5	4.19	3.24
EV/EBITDA	3,467.12	- -	- -	- -	- -	- -	- -	- -	32,090.02	1,190.21	481.54	119.06	62.49	20.95	21.35
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	330.52	97.6	25.21	25.5
EV/Cash Flow to Firm	139.21	241.74	- -	- -	- -	- -	129.47	338.17	284.1	- -	51.19	100.41	103.81	20.51	12.49
EV/Free Cash Flow to Firm	21.9	84.76	555.25	156.93	358.47	- -	48.27	78.66	70.22	- -	37.2	59.2	64.24	17.58	11.03
Diluted Market Cap	3,855	5,917	9,691	13,230	16,764	13,770	15,554	15,094	15,138	16,808	16,155	19,556	18,474	12,930	11,731
Diluted Enterprise Value	4,157	6,085	9,778	12,997	17,029	14,044	16,130	15,431	15,559	17,246	16,657	19,925	18,814	12,589	11,025
EV per Share	35.75	48.37	69.41	88.33	105.2	82.2	87.9	83.72	85.14	87.81	88.76	102.42	96.54	62.91	54.45
TTM Sales	441	501	548	749	890	1,117	1,314	1,491	1,704	1,860	1,846	2,096	2,419	2,854	3,221
TTM EBITDA	1	-66	-119	-115	-234	-107	-52	-59	- -	13	34	159	290	571	489
TTM Operating Income	-34	-110	-155	-160	-282	-204	-140	-155	-105	-92	-74	57	186	474	409
TTM Cash Flow to Firm	29	24	-48	-35	-181	-200	118	44	54	-394	317	189	175	583	836
TTM Free Cash Flow to Firm	183	69	17	82	47	-52	318	188	217	-256	436	321	282	680	947

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	22.33	95.16	1,233.27	283.66	2,055.95	-173.3	81.66	91.58	71.52	75.41	38.12	63.61	69.22	19.29	12.49
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	330.52	97.6	25.21	25.5
Enterprise Value	4,008	5,818	9,562	12,928	16,834	13,644	15,332	14,823	15,243	15,876	16,231	18,975	18,133	11,955	10,443
Low Price	23.09	31.91	49.71	55.04	88.51	62.12	80.1	75.81	62.88	68.25	71.59	70.73	76.02	61.15	50.76
EV/Sales	9.08	11.62	17.43	17.25	18.92	12.22	11.67	9.94	8.95	8.53	8.79	9.05	7.5	4.19	3.24
EV/EBITDA	3,467.12	- -	- -	- -	- -	- -	- -	- -	32,090.02	1,190.21	481.54	119.06	62.49	20.95	21.35
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.56	- -	135.44	108.03	29.26	32.67
Price/Earnings Average	-59.19	-41.17	-49.54	-77.29	-109.1	-22.84	-132.36	-211.24	-619.86	19.37	-229.95	113.34	105.06	35.94	32.61
Price/Earnings High	-74.06	-55.7	-63.01	-105.26	-141.35	-27.82	-149.79	-244.78	-751.73	27.93	-263.09	143.39	131.95	44.18	40.41
Price/Earnings Low	-48.09	-33.56	-38.83	-60.13	-82.44	-16.36	-119.37	-173.85	-472.07	14.45	-204.28	92.57	85.17	27.22	27.9
Price/Book Value	-9.07	-10.97	-13.54	-15.57	-16.41	-9.04	-9.5	-8.9	-8.8	-18.41	-17.36	-24.3	-29.15	-64.22	73.82
Price/Book Value Average	-7.5	-8.73	-12.21	-12.19	-18.35	-9.47	-9.46	-9.63	-8.59	-19.21	-15.83	-20.33	-28.34	-78.87	73.69
Price/Book Value High	-9.38	-11.81	-15.53	-16.6	-23.77	-11.53	-10.71	-11.16	-10.42	-27.69	-18.12	-25.73	-35.6	-96.97	91.31
Price/Book Value Low	-6.09	-7.12	-9.57	-9.48	-13.87	-6.78	-8.53	-7.92	-6.54	-14.32	-14.07	-16.61	-22.98	-59.74	63.05
Price/Tangible Book Value	7.12	7.39	8.62	10.05	11.03	6.82	7.43	6.62	6.13	4.54	4.39	4.71	4.06	2.4	2.01
Price/Tangible Book Value Average	5.89	5.88	7.77	7.86	12.33	7.14	7.4	7.16	5.99	4.74	4	3.94	3.95	2.95	2
Price/Tangible Book Value High	7.37	7.95	9.89	10.71	15.98	8.7	8.37	8.29	7.26	6.83	4.58	4.99	4.96	3.62	2.48
Price/Tangible Book Value Low	4.78	4.79	6.09	6.12	9.32	5.12	6.67	5.89	4.56	3.53	3.56	3.22	3.2	2.23	1.71
Price/Sales	8.73	11.82	17.67	17.66	18.84	12.31	11.84	10.11	8.88	8.52	8.75	9.15	7.49	4.38	3.54
Price/Sales Average	7.22	9.4	15.93	13.82	21.06	12.89	11.79	10.94	8.67	8.89	7.98	7.65	7.28	5.37	3.53
Price/Sales High	9.03	12.72	20.26	18.82	27.29	15.7	13.35	12.67	10.52	12.82	9.13	9.68	9.14	6.61	4.38
Price/Sales Low	5.87	7.66	12.48	10.75	15.92	9.23	10.64	9	6.61	6.63	7.09	6.25	5.9	4.07	3.02
Price/Cash Flow	209.33	336.04	-169.03	-187.87	-76.37	-60.35	-1,776.14	746.08	313.66	185.73	53.05	109	113.72	21.8	13.77
Price/Cash Flow Average	173.03	267.34	-152.37	-147.04	-85.39	-63.16	-1,769.05	807.12	306.29	193.83	48.39	91.21	110.59	26.78	13.74
Price/Cash Flow High	216.51	361.72	-193.82	-200.25	-110.63	-76.94	-2,002.02	935.25	371.46	279.47	55.36	115.39	138.9	32.92	17.03
Price/Cash Flow Low	140.59	217.95	-119.43	-114.38	-64.53	-45.26	-1,595.48	664.24	233.27	144.55	42.98	74.5	89.66	20.29	11.76
Price/Free Cash Flow Average	18.46	75.71	1,111.76	222.01	2,298.56	-181.37	81.34	99.07	69.84	78.7	34.77	53.23	67.32	23.69	12.47
Price/Free Cash Flow High	23.1	102.44	1,414.19	302.36	2,978.14	-220.93	92.05	114.8	84.69	113.48	39.78	67.34	84.55	29.13	15.45
Price/Free Cash Flow Low	15	61.72	871.44	172.71	1,737.04	-129.95	73.36	81.53	53.19	58.69	30.89	43.47	54.58	17.95	10.67
EV/Sales Average	7.9	9.74	16.09	13.51	21.36	13.13	12.23	11.16	8.92	9.13	8.25	7.83	7.42	5.26	3.31
EV/Sales High	9.72	13.06	20.42	18.51	27.59	15.94	13.78	12.9	10.77	13.06	9.4	9.86	9.28	6.49	4.16
EV/Sales Low	6.55	8	12.64	10.44	16.21	9.48	11.07	9.23	6.85	6.87	7.36	6.43	6.04	3.95	2.8
EV/EBITDA Average	3,017.64	-74	-74.11	-88.39	-81.12	-136.55	-309.96	-280.41	32,007.96	1,273.24	452.07	102.98	61.87	26.28	21.82
EV/EBITDA High	3,710.31	-99.23	-94.07	-121.11	-104.77	-165.78	-349.31	-324.03	38,628.52	1,821.34	515.08	129.67	77.41	32.45	27.38
EV/EBITDA Low	2,500.83	-60.8	-58.25	-68.31	-61.58	-98.57	-280.64	-231.78	24,588.1	957.91	403.27	84.53	50.38	19.77	18.46
EV/EBIT Average	-102.93	-44.23	-56.9	-63.11	-67.52	-71.78	-115.02	-107.37	-145.04	-184.94	-204.99	285.89	96.63	31.63	26.06
EV/EBIT High	-126.56	-59.31	-72.22	-86.47	-87.21	-87.14	-129.62	-124.07	-175.04	-264.55	-233.56	359.98	120.91	39.05	32.7
EV/EBIT Low	-85.3	-36.34	-44.72	-48.77	-51.26	-51.81	-104.14	-88.75	-111.42	-139.14	-182.86	234.68	78.69	23.79	22.05
Last Price	34.38	49.2	70.35	90.4	104.76	82.84	89.17	85.15	84.55	87.69	88.35	103.49	96.42	65.73	59.43
High Price	35.56	52.96	80.67	96.36	151.75	105.61	100.51	106.74	100.13	131.95	92.2	109.56	117.77	99.25	73.51
Enterprise Value Average	3,488	4,875	8,823	10,122	19,008	14,666	16,068	16,647	15,204	16,984	15,238	16,413	17,953	14,999	10,672
Enterprise Value High	4,289	6,537	11,199	13,870	24,549	17,805	18,108	19,236	18,349	24,295	17,361	20,667	22,462	18,520	13,392
Enterprise Value Low	2,891	4,006	6,935	7,822	14,429	10,586	14,548	13,759	11,679	12,778	13,593	13,473	14,620	11,280	9,029

Shares Outstanding	115	126	143	149	162	173	176	178	180	182	184	186	189	191	192
Diluted Weighted Avg Shares	112	120	138	146	160	166	174	177	179	192	183	189	192	197	197
Basic Weighted Avg Shares	112	120	138	146	160	166	174	177	179	181	183	185	188	190	192
Revenue per Share	3.94	4.16	3.98	5.12	5.56	6.73	7.53	8.42	9.52	10.29	10.1	11.31	12.88	15.02	16.8
EBITDA per Share	0.01	-0.55	-0.86	-0.78	-1.46	-0.65	-0.3	-0.34	- -	0.07	0.18	0.86	1.54	3	2.55
Operating Income per Share	-0.3	-0.92	-1.13	-1.1	-1.76	-1.23	-0.8	-0.88	-0.59	-0.51	-0.41	0.31	0.99	2.5	2.14
Basic EPS, GAAP	-0.48	-0.95	-1.28	-0.92	-1.07	-3.8	-0.67	-0.44	-0.13	4.72	-0.35	0.76	0.89	2.25	1.82
Basic EPS from Cont Ops	-0.48	-0.95	-1.28	-0.92	-1.07	-3.8	-0.67	-0.44	-0.13	4.72	-0.35	0.76	0.89	2.25	1.82
Diluted EPS, GAAP	-0.48	-0.95	-1.28	-0.92	-1.07	-3.79	-0.67	-0.44	-0.13	4.46	-0.35	0.75	0.87	2.17	1.77
Diluted EPS from Cont Ops	-0.48	-0.95	-1.28	-0.92	-1.07	-3.79	-0.67	-0.44	-0.13	4.46	-0.35	0.75	0.87	2.17	1.77
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.16	0.15	-0.42	-0.48	-1.37	-1.37	-0.05	0.11	0.27	0.47	1.67	0.95	0.85	3.01	4.32
Free Cash Flow per Basic Share	-1.21	-0.22	-0.89	-1.28	-2.79	-2.27	-1.19	-0.7	-0.64	-0.29	1.01	0.24	0.27	2.5	3.74
Cash & Equivalents per Share	1.74	3.72	5.7	6.46	3.7	4.76	8	6.12	4.21	5.89	5.54	6.97	5.72	5.99	8.14
Book Value per Share	-3.79	-4.48	-5.2	-5.81	-6.38	-9.16	-9.39	-9.57	-9.61	-4.76	-5.09	-4.26	-3.31	-1.02	0.81
Tangible Book Value per Share	4.83	6.66	8.16	9	9.5	12.14	12.01	12.87	13.79	19.32	20.13	21.96	23.75	27.4	29.6

BioMarin Pharmaceutical Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)